John P Mills

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Future microbiology

Infection control and hospital epidemiology

Infectious diseases and therapy

University of Michigan Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Michigan Hospital

United States

Assistant Professor of Medicine :: Infectious Diseases

Publications

Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology 19 (7) (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology 19 (7) (2024)
Ann Fan Yang, Adrienne Sherman, Elizabeth Nazarian, Wolfgang Haas, Jason Mehr, Michele Pedrani, Thomas Kirn, Steven Brant, Susan E Boruchoff, Keith S Kaye, John P Mills
Evidence of transmission of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae through a gastrointestinal endoscope without an elevator channel. Infection control and hospital epidemiology (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology 19 (7) (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology (2024)
John P Mills, Julia Mantey, Marco Cassone, Keith S Kaye, Lona Mody
Epidemiology of resistant gram-negative bacteria in nursing homes. Infection control and hospital epidemiology (2023)
John P Mills, Keith S Kaye, Richard Evans, Elizabeth Salzman, Jason Pogue, Kayoko Hayakawa, Dror Marchaim, Pansy Awasthy, Madiha Salim, Emily T Martin
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Infections in Metro Detroit: Early Dominance of the ST-131 Clone. Infectious diseases and therapy 9 (3) (2020)
A Rekha Murthy, Jennifer A Hanrahan, Sonali D Advani, Muhammad Salman Ashraf, John P Mills, Lona Mody, David K Henderson, Mary K Hayden, David J Weber, Sharon B Wright, Hilary M Babcock, Judith Guzman-Cottrill, Sarah D Haessler, Clare Rock, Trevor C Van Schooneveld, Corey Forde, Latania K Logan, Anurag M Malani
Preparing nursing homes for a second wave of coronavirus disease 2019 (COVID-19). Infection control and hospital epidemiology 42 (10) (2020)
John P Mills, Ziwei Zhu, Julia Mantey, Savannah Hatt, Payal Patel, Keith S Kaye, Kristen Gibson, Marco Cassone, Bonnie Lansing, Lona Mody
The devil is in the details: Factors influencing hand hygiene adherence and contamination with antibiotic-resistant organisms among healthcare providers in nursing facilities. Infection control and hospital epidemiology 40 (12) (2019)

John P Mills.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

John P Mills